P. pastoris Promoters for Diploid Protein Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current recombinant protein production methods, particularly in E. coli, face challenges in achieving efficient and cost-effective production of biologically active proteins due to kinetic limitations in folding and aggregation, while mammalian tissue culture systems are expensive and complex. There is a need for a more efficient and cost-effective expression system that can produce active heterologous proteins, especially eukaryotic proteins, with unpredictable expression levels and secretion efficiency in P. pastoris.
Innovation Solution
Development of novel inducible promoters derived from P. pastoris, specifically the ADH1, ENO1, and GUT1 genes, integrated into expression vectors for regulated expression of structural genes, enabling the secretion of heteromultimeric proteins in mating competent yeast strains, particularly diploid P. pastoris, to optimize protein production and secretion.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If E. coli is used for recombinant protein production, then production cost and ease of manipulation are improved, but protein folding efficiency and biological activity are worsened
Solution Approach 1:
The patent uses P. pastoris as an intermediary expression system between E. coli and mammalian cells. This yeast provides eukaryotic protein folding capabilities and post-translational modification machinery while maintaining ease of manipulation similar to bacterial systems, thus mediating the trade-off between manufacturability and protein quality
2Reliability
If mammalian tissue culture systems are used for protein production, then protein folding and post-translational modification are improved, but production cost and system complexity are worsened
Solution Approach 1:
The patent employs P. pastoris yeast cells as a disposable, cost-effective expression system that provides eukaryotic protein processing capabilities without the high complexity and cost of mammalian tissue culture. The yeast can be rapidly grown and discarded after protein production, eliminating the need for complex animal-derived components
3Reliability
If P. pastoris is used for heterologous protein expression, then protein processing and folding are improved, but expression level predictability is worsened
Solution Approach 1:
The patent systematically varies key parameters including promoter selection (AOX1, GAP, PGK1), carbon source composition, induction timing, and culture conditions to optimize and predict expression levels in P. pastoris. This parameter optimization approach transforms the unpredictable expression system into a controllable and predictable platform
4Ease of manufacture
If secretion of heterologous proteins is attempted in P. pastoris, then purification simplicity is improved, but secretion efficiency is worsened
Solution Approach 1:
The patent uses engineered secretion signal sequences as intermediaries to facilitate efficient protein secretion. These optimized signal peptides act as mediators between the heterologous protein and the P. pastoris secretory pathway, enabling high-efficiency secretion while maintaining purification simplicity
Data Source
AI summary
Novel promoters which are derived from P. pastoris pastoris which are inducible or repressible under specific growth conditions are provided. These promoters are useful for regulating the expression of a desired structural gene, e.g., a mammalian polypeptide. Particularly preferred is the use of these novel promoters to regulate gene expression in polyploidal yeast such as diploidal P. pastoris produced by mating or spheroplast fusion.